Daklinza Drug Interactions
Currently displaying a list of 255 drugs known to interact with Daklinza (daclatasvir).
- 60 major drug interactions
- 190 moderate drug interactions
- 5 minor drug interactions
Medications known to interact with Daklinza
Note: Showing generic names only.
A
- abametapir topical
- abrocitinib
- acarbose
- acetohexamide
- adagrasib
- afatinib
- albiglutide
- aliskiren
- alogliptin
- alpelisib
- ambrisentan
- amprenavir
- anisindione
- apalutamide
- apixaban
- aprepitant
- artesunate
- asciminib
- atazanavir
- atogepant
- atorvastatin
- avacopan
B
- belzutifan
- berotralstat
- betrixaban
- bexagliflozin
- binimetinib
- boceprevir
- bosentan
- bosutinib
- brentuximab
- brigatinib
- brincidofovir
- bromocriptine
C
- canagliflozin
- capivasertib
- capmatinib
- carbamazepine
- cenobamate
- ceritinib
- cerivastatin
- chloramphenicol
- chlorpropamide
- ciprofloxacin
- clarithromycin
- clofarabine
- clotrimazole
- cobicistat
- cobimetinib
- colchicine
- conivaptan
- crizotinib
- cyclosporine
D
- dabigatran
- dabrafenib
- danicopan
- dapagliflozin
- darunavir
- daunorubicin
- daunorubicin liposomal
- delavirdine
- dexamethasone
- dicumarol
- digoxin
- diltiazem
- docetaxel
- doxorubicin
- doxorubicin liposomal
- dronedarone
- dulaglutide
- duvelisib
E
- echinacea
- edoxaban
- efavirenz
- elacestrant
- eluxadoline
- empagliflozin
- encorafenib
- enzalutamide
- epirubicin
- erdafitinib
- erlotinib
- ertugliflozin
- erythromycin
- etoposide
- etravirine
- everolimus
- exenatide
F
- fedratinib
- fexinidazole
- fexofenadine
- fidaxomicin
- flibanserin
- fluconazole
- fluvastatin
- fosamprenavir
- fosaprepitant
- fosphenytoin
- fostamatinib
G
I
- idarubicin
- idelalisib
- imatinib
- indacaterol
- indinavir
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- isavuconazonium
- itraconazole
- ivosidenib
K
L
- lapatinib
- larotrectinib
- lasmiditan
- lefamulin
- lenacapavir
- lenalidomide
- letermovir
- levoketoconazole
- linagliptin
- liraglutide
- lixisenatide
- lonafarnib
- lonapegsomatropin
- loperamide
- lorlatinib
- lovastatin
- lusutrombopag
M
- maraviroc
- mavacamten
- metformin
- mibefradil
- mifepristone
- miglitol
- mitapivat
- mitotane
- mitoxantrone
- mobocertinib
- modafinil
- momelotinib
- morphine
N
- nafcillin
- naldemedine
- naloxegol
- nateglinide
- nefazodone
- nelfinavir
- nevirapine
- nifedipine
- nilotinib
- niraparib
O
P
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- pazopanib
- pemigatinib
- pexidartinib
- phenobarbital
- phenytoin
- pioglitazone
- pirtobrutinib
- pitavastatin
- posaconazole
- pralsetinib
- pramlintide
- pravastatin
- primidone
- prucalopride
Q
R
- ranolazine
- red yeast rice
- relugolix
- repaglinide
- repotrectinib
- resmetirom
- revefenacin
- ribociclib
- rifabutin
- rifampin
- rifapentine
- rifaximin
- rimegepant
- ripretinib
- ritlecitinib
- ritonavir
- rivaroxaban
- rolapitant
- romidepsin
- rosiglitazone
- rosuvastatin
- rucaparib
S
- saquinavir
- saxagliptin
- selpercatinib
- semaglutide
- silodosin
- simeprevir
- simvastatin
- sirolimus
- sitagliptin
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sotagliflozin
- sotorasib
- st. john's wort
- stiripentol
T
- talazoparib
- telaprevir
- telithromycin
- telotristat
- terfenadine
- ticagrelor
- tipranavir
- tirzepatide
- tolazamide
- tolbutamide
- tolvaptan
- topotecan
- trofinetide
- troglitazone
- troleandomycin
- tucatinib
U
V
- venetoclax
- verapamil
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- voriconazole
- voxelotor
W
Z
Daklinza disease interactions
There is 1 disease interaction with Daklinza (daclatasvir) which include:
More about Daklinza (daclatasvir)
- Daklinza consumer information
- Check interactions
- Compare alternatives
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: NS5A inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.